Fig. 2From: MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathwayKnockout of MUC3A promoted sensitivity to chemotherapy and apoptosis of CRC. A Cell viability of CRC cells treated with multiple doses of 5-FU (0–20 µg/ml, 24 h). B C Apoptosis rate of CRC cells treated with 10 µg/ml 5-FU for 24 h. (**P < 0.01, ***P < 0.001) Back to article page